Skewed X-Chromosome Inactivation in EDA-Related X-Linked Hypohidrotic Ectodermal Dysplasia in a Moroccan Family
Main Article Content
Abstract
X-linked hypohidrotic ectodermal dysplasia (HED) is a rare genetic disorder caused by pathogenic variants in the EDA gene and characterized by variable involvement of ectoderm-derived tissues. The aim of this study is to describe the clinical and molecular features of a Moroccan family affected by X-linked HED, with particular emphasis on the role of X-chromosome inactivation in phenotypic variability among female carriers. Clinical and genetic investigations identified the pathogenic EDA variant c.467G>A (p.Arg156His) in an affected boy and his heterozygous mother. Notably, the mother exhibited a more severe ectodermal phenotype than typically observed in female carriers. This observation highlights the likely impact of skewed X-chromosome inactivation on disease expression and underscores its importance for genotype–phenotype interpretation, genetic counseling, and multidisciplinary care.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Cluzeau C, Hadj-Rabia S, Jambou M, et al.
Only four genes (EDA, EDAR, EDARADD, WNT10A) account for 90% of hypohidrotic ectodermal dysplasia cases. Human Mutation. 2011;32(1):70–72.doi:10.1002/humu.21384
II. Mikkola ML. Molecular aspects of hypohidrotic ectodermal dysplasia. American Journal of Medical Genetics Part A. 2009; 149A(9):2031–2036.doi:10.1002/ajmg.a.32855
III. Lexner MO, Bardow A, Juncker I, et al. X-linked hypohidrotic ectodermal dysplasia: genetic and dental findings in heterozygous females. Clinical Genetics. 2008;74(3):252–259.doi:10.1111/j.1399-0004.2008.01052.x
IV. Puck JM, Willard HF.X inactivation in females with X-linked disease. New England Journal of Medicine. 1998;338(5):325–328.doi:10.1056/NEJM199801293380507
V. Hammersen J, Wohlfart S, Goecke T, et al. Reliability of genotype–phenotype correlations in hypohidrotic ectodermal dysplasia caused by EDA mutations. American Journal of Medical Genetics Part A. 2011;155A(3):599–607.doi:10.1002/ajmg.a.33855